OTCMKTS:ETBI - Eastgate Biotech Stock Price, News & Analysis

$0.0078
0.00 (0.00 %)
(As of 08/18/2019 06:59 AM ET)
Today's Range
$0.0067
Now: $0.0078
$0.0080
50-Day Range
$0.0058
MA: $0.01
$0.0080
52-Week Range
$0.0021
Now: $0.0078
$0.0125
Volume245,762 shs
Average Volume923,019 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes. It is also developing natural products and dietary supplements, including E-drops Nano and PURALEN that are self-nanoemulsifying compositions containing natural essential oils for oral administration; Glucora, a soft gelatin capsule with Banaba extract in self-emulsifying formulation for oral administration; URBAN POWER, a soft gelatin capsule with Ursolic acid and Banaba extract in self-emulsifying formulation for oral administration; Vitamin D3 nanoemulsion, a nanoemulsion with cholecalciferol; and Cleanezze, a hand sanitizer containing oil. The company was formerly known as Eastgate Acquisitions Corporation and changed its name to Eastgate Biotech Corp. in December 2014. Eastgate Biotech Corp. was founded in 1999 and is based in North York, Canada.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ETBI
Previous SymbolOTCMKTS:ESAQ
CUSIPN/A
CIKN/A
Phone+1-801-3223401

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees2
Next Earnings DateN/A
OptionableNot Optionable

Receive ETBI News and Ratings via Email

Sign-up to receive the latest news and ratings for ETBI and its competitors with MarketBeat's FREE daily newsletter.


Eastgate Biotech (OTCMKTS:ETBI) Frequently Asked Questions

What is Eastgate Biotech's stock symbol?

Eastgate Biotech trades on the OTCMKTS under the ticker symbol "ETBI."

Has Eastgate Biotech been receiving favorable news coverage?

News stories about ETBI stock have trended negative recently, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Eastgate Biotech earned a news sentiment score of -2.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Eastgate Biotech.

Who are some of Eastgate Biotech's key competitors?

What other stocks do shareholders of Eastgate Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Eastgate Biotech investors own include Delcath Systems (DCTHD), Meet Group (MEET), NeoGenomics (NEO), Aphria (APHA), JPMorgan Chase & Co. (JPM), Nokia Oyj (NOK), Altaba (AABA), Achillion Pharmaceuticals (ACHN), AcelRx Pharmaceuticals (ACRX) and Advanced Micro Devices (AMD).

Who are Eastgate Biotech's key executives?

Eastgate Biotech's management team includes the folowing people:
  • Ms. Anna E. Gluskin, CEO & Director (Age 65)
  • Ms. Rosella C. Perri, Pres, Sec., Treasurer & Director (Age 51)
  • Dr. Mirjana Hasanagic, VP of Natural Products (Age 52)
  • Dr. Joseph Schwarz Ph.D., Chief Scientific Officer (Age 63)
  • Dr. Michael Weisspapir M.D., Ph.D., Chief Medical Officer (Age 61)

How do I buy shares of Eastgate Biotech?

Shares of ETBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Eastgate Biotech's stock price today?

One share of ETBI stock can currently be purchased for approximately $0.0078.

What is Eastgate Biotech's official website?

The official website for Eastgate Biotech is http://www.eastgatebiotech.com/.

How can I contact Eastgate Biotech?

Eastgate Biotech's mailing address is 2681 E Parleys Way Ste 204, SALT LAKE CITY, UT 84109-1668, United States. The company can be reached via phone at +1-801-3223401.


MarketBeat Community Rating for Eastgate Biotech (OTCMKTS ETBI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  83 (Vote Outperform)
Underperform Votes:  80 (Vote Underperform)
Total Votes:  163
MarketBeat's community ratings are surveys of what our community members think about Eastgate Biotech and other stocks. Vote "Outperform" if you believe ETBI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ETBI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel